From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Parivar K, Rehman A, Ara J, Nahid S, Shaharyar A
However, L-cysteine cannot be taken as a supplement since its highly unstable and has poor oral bioavailability
The right choice depends on your specific situation
Abbreviations GLP-1RAs Glucagon-like peptide-1 receptor agonists T2DM Type 2 diabetes mellitus DPP-4 Dipeptidyl peptidase IV GLP-1R Glucagon-like peptide-1 receptor cAMP Cyclic adenosine monophosphate PKA Protein kinase A PI3K Phosphatidylinositol 3-kinase Akt Protein kinase B AD Alzheimers diseases TRPV1 Transient receptor potential vanilloid 1 OA Osteoarthritis KOA Knee OA MIA Monoiodoacetate IL-6 Interleukin 6 PGE2 Prostaglandin E2 NO Nitric oxide ER Endoplasmic reticulum IL-1 Interleukin-1 MMP-3 Matrix metalloproteinases-3 MMP-13 Matrix metalloproteinases-13 ROS Reactive oxygen species BMI Body mass index IBS Irritable bowel syndrome ATP Adenosine triphosphate SERT Serotonin transporter TPH-1 Tryptophan hydroxylase-1 AC Adenylate cyclase LPS Lipopolysaccharide WAS Water avoidance stress IBS-C Constipation-predominant IBS SNL Spinal nerve ligation SCI Spinal cord injury CHOP C/EBP homologous transcription factor protein GRP78 Glucose regulatory protein 78 PSNT Partial sciatic nerve transection L
